Evidence map›Paper›PMID 31720212›Full record

ArticleMetabolic engineering communications2019

Overproduction of gentamicin B in industrial strain

Yingying Chang, Baozhong Chai, Yunkun Ding, Min He, Linghui Zheng, Yun Teng, Zixin Deng, Yi Yu, Tiangang Liu

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolic engineering communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Application of Cas12j forBiomolecules · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yingying ChangKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
Baozhong ChaiZhejiang Key Laboratory of Antifungal Drugs, Zhejiang Hisun Pharmaceutical Co, Ltd, Taizhou, 318000, China.
Yunkun DingKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
Min HeZhejiang Key Laboratory of Antifungal Drugs, Zhejiang Hisun Pharmaceutical Co, Ltd, Taizhou, 318000, China.
Linghui ZhengZhejiang Key Laboratory of Antifungal Drugs, Zhejiang Hisun Pharmaceutical Co, Ltd, Taizhou, 318000, China.
Yun TengZhejiang Key Laboratory of Antifungal Drugs, Zhejiang Hisun Pharmaceutical Co, Ltd, Taizhou, 318000, China.
Zixin DengKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
Yi YuKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
Tiangang LiuKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
Zhejiang Hisun Pharmaceutical (China) · CNWuhan University · CNWuhan Institute of Bioengineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pharmaceutical industry, isepamicin is mainly manufactured from gentamicin B, which is produced by

Indexed as

CRISPR/Cas9GenRGenSGentamicin BMicromonospora echinospora

Identifiers

PMID31720212
PMCPMC6838515
OpenAlexW2962710893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.